TIAA CREF INVESTMENT MANAGEMENT LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$8,481,000
+9.6%
526,796
-0.4%
0.01%0.0%
Q4 2018$7,740,000
-60.5%
529,018
-50.9%
0.01%0.0%
Q3 2018$19,576,000
+121.0%
1,077,360
+105.2%
0.01%0.0%
Q2 2018$8,857,000
-4.8%
525,029
+10.6%
0.01%0.0%
Q1 2018$9,299,000
+59.4%
474,705
+64.9%
0.01%
+50.0%
Q4 2017$5,832,000
+6.5%
287,845
-8.7%
0.00%0.0%
Q3 2017$5,474,000
+44.5%
315,162
+6.6%
0.00%
+33.3%
Q2 2017$3,789,000
-1.1%
295,570
-0.0%
0.00%0.0%
Q1 2017$3,831,000
+25.2%
295,613
-4.6%
0.00%
+50.0%
Q4 2016$3,061,000
-22.3%
309,821
-5.0%
0.00%0.0%
Q3 2016$3,938,000
+33.4%
325,965
-4.7%
0.00%0.0%
Q2 2016$2,952,000
-14.0%
342,036
-5.6%
0.00%
-33.3%
Q1 2016$3,432,000
-53.0%
362,450
-14.0%
0.00%
-40.0%
Q4 2015$7,303,000
+23.1%
421,386
-4.6%
0.01%0.0%
Q3 2015$5,932,000
-43.2%
441,722
-4.5%
0.01%
-28.6%
Q2 2015$10,440,000
+55.4%
462,335
-1.7%
0.01%
+40.0%
Q1 2015$6,719,000
+42.6%
470,495
-3.6%
0.01%
+66.7%
Q4 2014$4,711,000
+1.0%
488,183
-4.8%
0.00%0.0%
Q3 2014$4,664,000
-18.2%
512,546
-11.2%
0.00%
-25.0%
Q2 2014$5,703,000
+26.1%
577,221
+62.1%
0.00%
+33.3%
Q1 2014$4,523,000
-15.9%
356,131
-0.8%
0.00%
-25.0%
Q4 2013$5,381,000
+36.5%
358,941
+0.5%
0.00%
+33.3%
Q3 2013$3,941,000
+36.1%
357,004
-2.1%
0.00%
+50.0%
Q2 2013$2,895,000364,6350.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders